Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of Treg cell frequency in acute myeloid leukemia.

International journal of hematology - 1 Nov 2013

Yang Wenjuan, Xu Yunxiao

Abstract excerpt

This study was designed to investigate the clinical significance of peripheral blood CD4(+) CD25(+) CD127 low-regulatory T (T(reg)) cells in acute myeloid leukemia (AML) patients. T(reg) cells in the peripheral blood of 80 AML patients and 35 age-matched healthy controls were counted by flow cytometry. Correlations between the frequency of circulating T(reg) cells and disease status, treatment outcome, or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to CD5 Antigens
Share to Immunophenotyping

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-2 Receptor alpha Subunit

Share to Interleukin-7 Receptor alpha Subunit

Share to Leukemia, Myeloid, Acute

Share to Lymphocyte Count

Share to T-Lymphocytes, Regulatory

Source

Identifiers

PMID: 24142765
DOI: 10.1007/s12185-013-1436-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of Treg cell frequency in acute myeloid leukemia.PMID 24142765Read ↗

Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease.Semantic proximity Read ↗

Regulatory T cell therapy for Graft-versus-Host DiseaseSemantic proximity Read ↗

Identification of STAT4 as a biomarker associated with tumor immunity and prognosis in acute myeloid leukemiaSemantic proximity Read ↗

Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma.Semantic proximity Read ↗

CD4+CD25high regulatory cells in peripheral blood of cancer patients.Semantic proximity Read ↗

Regulatory Myeloid Suppressor Cells in Health and DiseaseSemantic proximity Read ↗

After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia.Semantic proximity Read ↗

Human regulatory T cells in allogeneic stem cell transplantationSemantic proximity Read ↗

Decrease and impaired function of circulating mucosa-associated invariant T cells in acute myeloid leukemiaSemantic proximity Read ↗

Immunosuppressive role of CD11b+ CD33+ HLA-DR- myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia.Semantic proximity Read ↗

Natural and in vitro-generated regulatory T-cell subsets differentially modulate phenotype and drug response in K562 leukemic cells.Semantic proximity Read ↗

Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.